AZCEMFY

Serial Number 79420543
661

Registration Progress

Application Filed
Feb 21, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AZCEMFY

Basic Information

Serial Number
79420543
Filing Date
February 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Oct 14, 2025
Application
Pending
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Oct 18, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Oct 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 14, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 27, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 27, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Aug 16, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 15, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 9, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 9, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Apr 3, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; immunomodulators and immunosuppressive agents being pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology

Classification

International Classes
005